Everolimus trial in a refractory epilepsy case secondary to a PI3K-Akt-mTOR signaling pathway mosaic mutation: from physiopathological theory to clinical practice
Affiliation auteurs | !!!! Error affiliation !!!! |
Titre | Everolimus trial in a refractory epilepsy case secondary to a PI3K-Akt-mTOR signaling pathway mosaic mutation: from physiopathological theory to clinical practice |
Type de publication | Journal Article |
Year of Publication | 2019 |
Auteurs | Hadouiri N., Darmency V., Riviere J., Guibaud L., Sorlin A., Carmignac V., Riviere J., Luu M., Bardou M., Thauvin-Robinet C., Vabres P., Faivre L. |
Journal | EUROPEAN JOURNAL OF HUMAN GENETICS |
Volume | 27 |
Pagination | 1890 |
Date Published | OCT |
Type of Article | Meeting Abstract |
ISSN | 1018-4813 |